Skip to main
HSIC
HSIC logo

Henry Schein (HSIC) Stock Forecast & Price Target

Henry Schein (HSIC) Analyst Ratings

Based on 11 analyst ratings
Hold
Strong Buy 9%
Buy 36%
Hold 55%
Sell 0%
Strong Sell 0%

Bulls say

Henry Schein Inc demonstrated robust revenue growth across its key segments, with medical products revenue rising by 6.3% as reported, and the global technology segment revenues increasing by 7.4%. Additionally, the company's overall international business experienced a reported growth of 4.7%, indicating strong market performance. The expectation of mid-single-digit percentage growth in adjusted EBITDA further reinforces a positive financial outlook for the company.

Bears say

Henry Schein's recent financial performance has shown significant weaknesses, with a gross margin of 31.4% representing a decline of 110 basis points year-over-year, which also fell short of estimates by 60 basis points. The company's US dental merchandise revenue decreased by 1.2% due to pricing pressures, while international merchandise revenue, although reported up by 1.9%, faced a local internal decline of 0.4%. These factors contribute to a negative outlook for the company, highlighting issues with profitability and revenue growth in critical segments.

Henry Schein (HSIC) has been analyzed by 11 analysts, with a consensus rating of Hold. 9% of analysts recommend a Strong Buy, 36% recommend Buy, 55% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Henry Schein (HSIC) Forecast

Analysts have given Henry Schein (HSIC) a Hold based on their latest research and market trends.

According to 11 analysts, Henry Schein (HSIC) has a Hold consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $76.82, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $76.82, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Henry Schein (HSIC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.